Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Daniel Zambón"'
Autor:
Christina Baslari, Hicham Maskrot, Wilfried Pacquentin, Sonia Sousa Nobre, Timothée Delacroix, Daniel Zambon, Rachid Mahiou
Publikováno v:
Additive Manufacturing Letters, Vol 8, Iss , Pp 100186- (2024)
Transition to circular economy requires the production of sustainable and eco-designed materials that help to reduce environmental impacts of metallic components. The development of sensing layers providing luminescent tracking functionalities is a p
Externí odkaz:
https://doaj.org/article/08f213114ece4e91b48239b5a329623f
Autor:
Sonia Muñoz, Manuel Merlos, Daniel Zambón, Cristina Rodríguez, Joan Sabaté, Emilio Ros, Juan C. Laguna
Publikováno v:
Journal of Lipid Research, Vol 42, Iss 12, Pp 2069-2076 (2001)
In a randomized, cross-over feeding trial involving 10 men with polygenic hypercholesterolemia, a control, Mediterranean-type cholesterol-lowering diet, and a diet of similar composition in which walnuts replaced ~35% of energy from unsaturated fat,
Externí odkaz:
https://doaj.org/article/35abee197d5649f4b6487e3f1d352d54
Autor:
Eduardo Mansilla, Vanina Díaz Aquino, Daniel Zambón, Gustavo Horacio Marin, Karina Mártire, Gustavo Roque, Thomas Ichim, Neil H. Riordan, Amit Patel, Flavio Sturla, Gustavo Larsen, Rubén Spretz, Luis Núñez, Carlos Soratti, Ricardo Ibar, Michiel van Leeuwen, José María Tau, Hugo Drago, Alberto Maceira
Publikováno v:
Stem Cells International, Vol 2011 (2011)
One of the most important and complex diseases of modern society is metabolic syndrome. This syndrome has not been completely understood, and therefore an effective treatment is not available yet. We propose a possible stem cell mechanism involved in
Externí odkaz:
https://doaj.org/article/ed9b4ad097384c118a5f0313e858e047
Autor:
Rodrigo Alonso, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, Jose Luis Díaz-Díaz, Juan Sanchez Muñoz-Torrero, Manuel J Romero, Raimundo de Andrés, Daniel Zambón, María Dolores Mañas, Francisco Fuentes-Jiménez, Rocío Aguado, Pilar Alvarez-Baños, Francisco Arrieta, Pablo Gonzalez-Bustos, José Cepeda, Mercedes Martin-Ordiales, Daniel Mosquera, Alfredo Michan, Leopoldo Perez de Isla, Rosa Argueso, Pedro Mata
Publikováno v:
European Journal of Preventive Cardiology. 30:320-328
AimsMost heterozygous familial hypercholesterolaemia (FH) patients require intensive lipid-lowering therapy (LLT) including PCSK9 inhibitors (PCSK9is) to reach current low-density lipoprotein cholesterol (LDL-C) goals. Persistence with chronic treatm
Autor:
Antonio Gallo, Leopoldo Pérez de Isla, Sybil Charrière, Alexandre Vimont, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José L. Díaz-Díaz, Daniel Zambón, Philippe Moulin, Eric Bruckert, Pedro Mata, Sophie Béliard, Denis Angoulvant, Sophie Beliard, Franck Boccara, Bertrand Cariou, Valérie Carreau, Alain Carrie, Sybil Charrieres, Yves Cottin, Mathilde Di Filippo, Pierre Henri Ducluzeau, Sonia Dulong, Vincent Durlach, Michel Farnier, Emile Ferrari, Dorota Ferrieres, Jean Ferrieres, Philippe Giral, Sophie Gonbert, Regis Hankard, Jocelyn Inamo, Olga Kalmykova, Michel Krempf, Julie Lemale, François Paillard, Noel Peretti, Agnes Perrin, Alain Pradignac, Jean Pierre Rabes, Vincent Rigalleau, François Schiele, Ariane Sultan, Patrick Tounian, René Valero, Bruno Verges, Cecile Yelnik, Olivier Ziegler, Rocío Aguado, Ma Pilar Álvarez-Baños, Rosa Argüeso, Francisco Arrieta, Miguel Ángel Barba, Marta Casañas, José María Cepeda, Raimundo De Andrés, Gonzalo Díaz-Soto, Jose Luis Díaz-Diaz, Marta Dieguez, Ceferino Faedo, Francisco Fuentes, Juan A. Garrido, Aurora González, Pablo González-Bustos, Ma Dolores Mañas, Marta Mauri, Juan Diego Mediavilla, Alfredo Michán, Pablo Miramontes, Ovidio Muñiz, Leire Pérez, Leopoldo Perez De Isla, Xavier Pintó, Manuel J. Romero, Patricia Rubio, Juan F. Sánchez Muñoz-Torrero, Jose I. Vidal-Pardo
Publikováno v:
JACC: Cardiovascular Imaging
JACC: Cardiovascular Imaging, Elsevier/American College of Cardiology, 2021, ⟨10.1016/j.jcmg.2021.06.011⟩
JACC: Cardiovascular Imaging, 2021, 14 (12), pp.2414-2424. ⟨10.1016/j.jcmg.2021.06.011⟩
JACC: Cardiovascular Imaging, Elsevier/American College of Cardiology, 2021, ⟨10.1016/j.jcmg.2021.06.011⟩
JACC: Cardiovascular Imaging, 2021, 14 (12), pp.2414-2424. ⟨10.1016/j.jcmg.2021.06.011⟩
International audience; ObjectivesThis study aimed at investigating the additional contribution of coronary artery calcium (CAC) score to SAFEHEART (Spanish Familial Hypercholesterolemia Cohort Study) risk equation (SAFEHEART-RE) for cardiovascular r
Autor:
Patricia Rubio, Raimundo de Andrés, Raquel Arroyo-Olivares, Pedro Mata, María Dolores Mañas, Francisco Fuentes-Jiménez, Marta Casañas, Pilar Alvarez-Baños, Francisco Arrieta, Ovidio Muñiz-Grijalvo, Rodrigo Alonso, Leopoldo Pérez-Isla, José María Cepeda, Marta Dieguez, Juan Francisco Sánchez Muñoz-Torrero, José Luis Díaz-Díaz, Daniel Zambón, Pablo Gonzalez-Bustos, Rocío Aguado, Rosa Argüeso
Publikováno v:
Journal of Clinical Lipidology. 15:584-592
PCSK9 inhibitors are a treatment option for patients with familial hypercholesterolemia not on low-density lipoprotein cholesterol goals despite the use of maximally tolerated high intensity-statins dose.To evaluate the efficacy of alirocumab and evo
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 33:29-36
Autor:
José Juan Gómez de Diego, Teresa Padró, Raimundo de Andrés, Leopoldo Pérez de Isla, Safeheart Investigators, Daniel Zambón, José Werenitzky, Pedro Mata, José Pablo Miramontes, Rodrigo Alonso, José Luis Díaz-Díaz, Francisco Fuentes, Ovidio Muñiz-Grijalvo, Adriana Saltijeral
Publikováno v:
Atherosclerosis. 317:52-58
Heterozygous familial hypercholesterolemia (FH) is associated with premature atherosclerotic cardiovascular disease. Semi-automated plaque characterization (SAPC) by coronary computed tomographic angiography (CTA) provides information regarding coron
Autor:
Leopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Daniel Zambón, Francisco Fuentes, Nelva Mata, Mar Piedecausa, M. Dolores Mañas, Juan F. Sánchez Muñoz-Torrero, José Pablo Miramontes-González, Raimundo de Andrés, Marta Mauri, Rocío Aguado, Ángel Brea, José M. Cepeda, José I. Vidal-Pardo, Ceferino Martínez-Faedo, Miguel Ángel Barba, Rosa Argüeso, Enrique Ruiz-Pérez, Alfredo Michán, Francisco Arrieta, María Riestra Fernández, Leire Pérez, José M. Pinilla, Gonzalo Díaz-Soto, Xavier Pintó, Teresa Padró, Lina Badimón, Pedro Mata, Begoña Perez-Corral, Fátima Almagro, Raquel Arroyo, Adriana Saltijeral, Daniel Mosquera, Marta Casañas, Julio Carbayo, Jose María Cepeda, Raimundo De Andrés, José L. Díaz, Marta Diéguez, María Riestra, José López-Miranda, Jesús Galiana, Jesús García-Cruces, Juan Antonio Garrido, Luis Irigoyen, Pedro L. Martínez, Lorena Suárez, Rosa M. Borrallo, Juan Diego Mediavilla, Fernando Jaén, Pablo González, Patricia Rubio, Pablo Miramontes, Juan L. Morera, Ovidio Muñiz, Aurora González, Francisca Pereyra, José Pastor, José Miguel Pinilla, Manuel J. Romero, Enrique Ruiz, M. Pilar Álvarez, Pedro Sáenz, Juan F. Sánchez, Consuelo Sanz, Jose I. Vidal
Publikováno v:
Revista Española de Cardiología. 73:828-834
Resumen Introduccion y objetivos El estudio SAFEHEART se diseno para analizar la situacion y mejorar el conocimiento de la hipercolesterolemia familiar heterocigota (HFH) en Espana. Nuestro objetivo es determinar la tasa de incidencia de eventos card
Autor:
Ricardo Usategui-Martín, José Pablo Miramontes-González, David Jiménez, Ovidio Muñiz-Grijalvo, Teresa Padró, Ana Elisa Rodríguez Gude, Francisco Fuentes Jiménez, Leopoldo Pérez de Isla, José Luis Díaz-Díaz, Pedro Mata, Rodrigo Alonso, Rogelio González-Sarmiento, Javier Martín-Vallejo, Daniel Zambón
Publikováno v:
Atherosclerosis. 285:17-22
Background and aims Heterozygous familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C). The magnitude of atherosclerotic cardiovascular disease (ASCVD) risk in FH patients